These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 840136)
1. [Investigations on the pharmacokinetics of pentoxifylline in chronic renal failure (authors transl)]. Schaefer K; von Herrath D; Hensel A; Grigoleit HG Med Klin; 1977 Feb; 72(6):204-6. PubMed ID: 840136 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of oral cefatrizine in patients with impaired renal function. Couet W; Fauvel JP; Laville M; Pozet N; Fourtillan JB Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):213-7. PubMed ID: 1869342 [TBL] [Abstract][Full Text] [Related]
3. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis. Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of norfloxacin in chronic renal failure. Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162 [TBL] [Abstract][Full Text] [Related]
5. Metabolism and pharmacokinetics of 14C-pentoxifylline in healthy volunteers. Bryce TA; Chamberlain J; Hillbeck D; Macdonald CM Arzneimittelforschung; 1989 Apr; 39(4):512-7. PubMed ID: 2751739 [TBL] [Abstract][Full Text] [Related]
6. A study of practolol elimination in all grades of chronic renal failure. Kaye CM; Kumana CR; Franklin DA; Baker LR Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):83-8. PubMed ID: 1165145 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cicletanine in patients with impaired renal function. Jungers P Drugs Exp Clin Res; 1988; 14(2-3):189-94. PubMed ID: 3416723 [TBL] [Abstract][Full Text] [Related]
8. The kinetics of aminosidine in renal patients with different degrees of renal failure. Novarini A; Montanari A; Bruschi G; Rossi E; Borghetti A; Migone L Clin Nephrol; 1975 Jul; 4(1):23-4. PubMed ID: 1157346 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of intravenous and oral pentoxifylline in healthy subjects. Beermann B; Ings R; Månsby J; Chamberlain J; McDonald A Clin Pharmacol Ther; 1985 Jan; 37(1):25-8. PubMed ID: 3965236 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients. Rames A; Poirier JM; LeCoz F; Midavaine M; Lecocq B; Grange JD; Poupon R; Cheymol G; Jaillon P Clin Pharmacol Ther; 1990 Mar; 47(3):354-9. PubMed ID: 2178853 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of anakinra in subjects with different levels of renal function. Yang BB; Baughman S; Sullivan JT Clin Pharmacol Ther; 2003 Jul; 74(1):85-94. PubMed ID: 12844139 [TBL] [Abstract][Full Text] [Related]
13. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril]. Haufe CC; Sierakowski B; Jansa U; Stein G Med Klin (Munich); 1994 Aug; 89(8):416-20. PubMed ID: 7968874 [TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of chronic renal insufficiency with Ibopamine (SB 7505), a new orally active dopamine-related drug. Stefoni S; Docci D; Vangelista A; Mosconi G; Colí L; Prandini R Clin Nephrol; 1982 Oct; 18(4):168-73. PubMed ID: 6754197 [TBL] [Abstract][Full Text] [Related]